Transplantation of human placenta-derived mesenchymal stem cells in a silk fibroin/hydroxyapatite scaffold improves bone repair in rabbits

Journal of Bioscience and Bioengineering

Volumn 118, Issue 5, 2014, Pages 593-598

  Jin, Jun ^a   Wang, Jun ^a   Huang, Jian ^a   Huang, Fang ^a   Fu, Jianhong ^a   Yang, Xinjing ^a   Miao, Zongning ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b No 3 People's Hospital   (China)

Author keywords

Bone; Human placenta derived mesenchymal stem cells; Hydroxyapatite; Silk fibroin; Tissue engineering

Indexed keywords

BONE; CELL CULTURE; CELL ENGINEERING; CELL MEMBRANES; CELLS; CYTOLOGY; FRACTURE; HYDROXYAPATITE; POLYMETHYL METHACRYLATES; POROUS MATERIALS; REPAIR; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BIODEGRADABLE SCAFFOLD; BONE TISSUE ENGINEERING; EXTRACELLULAR MATRIX COMPONENTS; FLOW-CYTOMETRIC ANALYSIS; HISTOLOGICAL ANALYSIS; MESENCHYMAL STEM CELL; OSTEOGENIC POTENTIAL; SILK FIBROIN;

SCAFFOLDS (BIOLOGY);

5' NUCLEOTIDASE; BIOMATERIAL; CALCIUM; CD34 ANTIGEN; CD45 ANTIGEN; CELL SURFACE PROTEIN; ENDOGLIN; HYDROXYAPATITE; SILK FIBROIN; SILK FIBROIN HYDROXYAPATITE SCAFFOLD; THY 1 ANTIGEN; UNCLASSIFIED DRUG; FIBROIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RETRIEVAL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE DEVELOPMENT; BONE REMODELING; BONE TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FRACTURE HEALING; HEMATOPOIETIC CELL; HUMAN; HUMAN PLACENTA DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NEW ZEALAND RABBIT; NONHUMAN; PLACENTA; RECANALIZATION; SCANNING ELECTRON MICROSCOPE; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE REPAIR; TISSUE SCAFFOLD; ANATOMY AND HISTOLOGY; ANIMAL; BONE; CHEMISTRY; CYTOLOGY; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; PREGNANCY; RABBIT; WOUND HEALING;

ORYCTOLAGUS CUNICULUS;

ANIMALS; BONE AND BONES; DURAPATITE; FEMALE; FIBROINS; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PLACENTA; PREGNANCY; RABBITS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84927173854     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2014.05.001     Document Type: Article

References (45)

1. Carulli C., Matassi F., Civinini R., Innocenti M. Tissue engineering applications in the management of bone loss. Clin. Cases Miner. Bone Metab. 2013, 10:22-25.
2. Tonelli F.M., Santos A.K., Gomes K.N., Lorençon E., Guatimosim S., Ladeira L.O., Resende R.R. Carbon nanotube interaction with extracellular matrix proteins producing scaffolds for tissue engineering. Int. J. Nanomed. 2012, 7:4511-4529.
3. Silva G.A., Coutinho O.P., Ducheyne P., Shapiro I.M., Reis R.L. The effect of starch and starch-bioactive glass composite microparticles on the adhesion and expression of the osteoblastic phenotype of a bone cell line. Biomaterials 2007, 28:326-334.
4. Jones A.C., Arns C.H., Hutmacher D.W., Milthorpe B.K., Sheppard A.P., Knackstedt M.A. The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 2009, 30:1440-1451.
5. Dietmar W.H. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21:2529-2543.
6. Rose F.R., Oreffo R.O. Bone tissue engineering: hope vs hype. Biochem. Biophys. Res. Commun. 2002, 292:1-7.
7. Orban J.M., Marra K.G., Hollinger J.O. Composition options for tissue-engineered bone. Tissue Eng. 2002, 8:529-539.
8. Mandal B.B., Kundu S.C. Osteogenic and adipogenic differentiation of rat bone marrow cells on non-mulberry and mulberry silk gland fibroin 3D scaffolds. Biomaterials 2009, 30:5019-5030.
9. Mandal B.B., Kundu S.C. Non-mulberry silk gland fibroin protein 3-D scaffold for enhanced differentiation of human mesenchymal stem cells into osteocytes. Acta Biomater. 2009, 5:2579-2590.
10. Gil E.S., Kluge J.A., Rockwood D.N., Rajkhowa R., Wang L., Wang X., Kaplan D.L. Mechanical improvements to reinforced porous silk scaffolds. J.Biomed. Mater. Res. A 2011, 99:16-28.
11. Rockwood D.N., Gil E.S., Park S.H., Kluge J.A., Grayson W., Bhumiratana S., Rajkhowa R., Wang X., Kim S.J., Vunjak-Novakovic G., Kaplan D.L. Ingrowth of human mesenchymal stem cells into porous silk particle reinforced silk composite scaffolds: an in vitro study. Acta Biomater. 2011, 7:144-151.
12. Mandal B.B., Grinberg A., Gil E.S., Panilaitis B., Kaplan D.L. Proc. Natl. Acad. Sci. USA 2012, 109:7699-7704.
13. Cao Y., Wang B. Biodegradation of silk biomaterials. Int. J. Mol. Sci. 2009, 10:1514-1524.
14. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., Lu H., Richmond J., Kaplan D.L. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
15. Jin H.J., Chen J., Karageorgiou V., Altman G.H., Kaplan D.L. Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 2004, 25:1039-1047.
16. Kim H.J., Kim U.J., Vunjak-Novakovic G., Min B.H., Kaplan D.L. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials 2005, 26:4442-4452.
17. Chang Y.J., Shih D.T., Tseng C.P., Hsieh T.B., Lee D.C., Hwang S.M. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006, 24:679-685.
18. Lee H.J., Jung J., Cho K.J., Lee C.K., Hwang S.G., Kim G.J. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes. Differentiation 2012, 84:223-231.
19. Kasper G., Mao L., Geissler S., Draycheva A., Trippens J., Kühnisch J., Tschirschmann M., Kaspar K., Perka C., Duda G.N., Klose J. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 2009, 27:1288-1297.
20. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
21. Semenov O.V., Koestenbauer S., Riegel M., Zech N., Zimmermann R., Zisch A.H., Malek A. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am. J. Obstet. Gynecol. 2009, 202:193.e1-193.e13.
22. Miao Z., Jin J., Chen L., Zhu J., Huang W., Zhao J., Qian H., Zhang X. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 2006, 30:681-687.
23. Semenov O.V., Koestenbauer S., Riegel M., Zech N., Zimmermann R., Zisch A.H., Malek A. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am. J. Obstet. Gynecol. 2010, 202:193.e1-193.e13.
24. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
25. Fan Z.X., Lu Y., Deng L., Li X.Q., Zhi W., Li-Ling J., Yang Z.M., Xie H.Q. Placenta-versus bone-marrow-derived mesenchymal cells for the repair of segmental bone defects in a rabbit model. FEBS J. 2012, 279:2455-2465.
26. Landis W.J., Song M.J., Leith A., McEwen L., McEwen B.F. Mineral and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction. J.Struct. Biol. 1993, 110:39-54.
27. Du C., Cui F.Z., Zhang W., Feng Q.L., Zhu X.D., de Groot K. Formation of calcium phosphate/collagen composites through mineralization of collagen matrix. J.Biomed. Mater. Res. 2000, 50:518-527.
28. Erisken C., Kalyon D.M., Wang H. Functionally graded electrospun polycaprolactone and beta-tricalcium phosphate nanocomposites for tissue engineering applications. Biomaterials 2008, 29:4065-4073.
29. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., Li L., Leet A.I., Seo B.M., Zhang L., Shi S., Young M.F. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 2007, 13:1219-1227.
30. Mygind T., Stiehler M., Baatrup A., Li H., Zou X., Flyvbjerg A., Kassem M., Bünger C. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials 2007, 28:1036-1047.
31. Bos G.D., Goldberg V.M., Powell A.E., Heiple K.G., Zika J.M. The effect of histocompatibility matching on canine frozen bone allografts. J.Bone Joint Surg. Am. 1983, 65:89-96.
32. Parolini O., Alviano F., Bagnara G.P., Bilic G., Bühring H.J., Evangelista M., Hennerbichler S., Liu B., Magatti M., Mao N., other 16 authors Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008, 26:300-311.
33. Prather W.R., Toren A., Meiron M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert Opin. Biol. Ther. 2008, 8:1241-1250.
34. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., Yen B.L. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006, 24:2466-2477.
35. Simioniuc A., Campan M., Lionetti V., Marinelli M., Aquaro G.D., Cavallini C., Valente S., Di Silvestre D., Cantoni S., Bernini F., other 7 authors Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Cardiovasc. Res. 2011, 90:546-556.
36. Liu D.S., Hui H.F., Chai X.B., Wang B., Qiu J. Construction of tissue-engineered cartilage using human placenta-derived stem cells. Sci. China Life Sci. 2010, 53:207-214.
37. Ringdén O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lönnies H., Marschall H.U., Dlugosz A., Szakos A., Hassan Z., other 4 authors Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
38. Le Blanc K., Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J.Intern. Med. 2007, 262:509-525.
39. Thein-Han W.W., Shah J., Misra R.D. Superior in vitro biological response and mechanical properties of an implantable nanostructured biomaterial: nanohydroxyapatite-silicone rubber composite. Acta Biomater. 2009, 5:2668-2679.
40. Liu L., Liu J., Wang M., Min S., Cai Y., Zhu L., Yao J. Preparation and characterization of nano-hydroxyapatite/silk fibroin porous scaffolds. J.Biomater. Sci. Polym. Ed. 2008, 19:325-338.
41. Kino R., Ikoma T., Yunoki S., Nagai N., Tanaka J., Asakura T., Munekata M. Preparation and characterization of multilayered hydroxyapatite/silk fibroin film. J.Biosci. Bioeng. 2007, 103:514-520.
42. Wang G., Yang H., Li M., Lu S., Chen X., Cai X. The use of silk fibroin/hydroxyapatite composite co-cultured with rabbit bone-marrow stromal cells in thehealing of a segmental bone defect. J.Bone Joint Surg. Br. 2010, 92:320-325.
43. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., Zichner L., Langer R., Vunjak-Novakovic G., Kaplan D.L. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 2005, 26:147-155.
44. Dal Pra I., Freddi G., Minic J., Chiarini A., Armato U. De novo engineering of reticular connective tissue in vivo by silk fibroin nonwoven materials. Biomaterials 2005, 26:1987-1999.
45. Datta N., Pham Q.P., Sharma U., Sikavitsas V.I., Jansen J.A., Mikos A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc. Natl. Acad. Sci. USA 2006, 103:2488-2493.